Physician profile
Mingi Choi
NPI 1902802846
$947.20
in general payments reported to CMS, 2019-2025
13 companies · $50.92 in 2025
The $50.92 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.80 · 2021: $348 · 2022: $312 · 2023: $143 · 2024: $37.57 · 2025: $50.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $224.67 | 2022-2023 | Invictus Mis |
| Abbott Laboratories | $191.21 | 2021 | |
| Intrinsic Therapeutics | $114.28 | 2022 | |
| Medtronic, INC. | $89.84 | 2021 | |
| Stryker Corporation | $82.07 | 2023-2024 | Prolift, Serrato |
| Boston Scientific Corporation | $63.75 | 2019-2021 | |
| Davol INC. | $50.92 | 2025 | Channel Drain |
| Nevro Corp. | $42.82 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.36 | 2022 | |
| Orthogenrx INC. | $15.81 | 2019 | |
| Ge Healthcare | $14.74 | 2022 | |
| Lilly USA, LLC | $14.46 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.27 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mingi Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.